# Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)

> **NCT01308905** · NA · UNKNOWN · sponsor: **Barbara Ann Karmanos Cancer Institute** · enrollment: 50 (estimated)

## Conditions studied

- Neuroblastoma

## Interventions

- **DEVICE:** FLT-PET

## Key facts

- **NCT ID:** NCT01308905
- **Lead sponsor:** Barbara Ann Karmanos Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-02
- **Primary completion:** 2018-02
- **Final completion:** 2018-02
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01308905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01308905, "Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01308905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*